← SynDRA
ETRASIMOD
SynDRA canonical compound SYN0038122 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | S1PR1 |
|---|
| Mechanism of action | sphingosine 1-phosphate receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- S1PR1 AGONIST
- Sphingosine 1-phosphate receptor Edg-1 agonist
- S1PR4 MODULATOR
- Sphingosine 1-phosphate receptor Edg-6 modulator
- S1PR1 MODULATOR
- Sphingosine 1-phosphate receptor Edg-1 modulator
- S1PR5 MODULATOR
- Sphingosine 1-phosphate receptor Edg-8 modulator
- sphingosine 1-phosphate receptor antagonist
Drug classes
ATC classes
- L04A · IMMUNOSUPPRESSANTS
Cross-references
Synonyms
- APD334
- APD-334
- APD-334(FREE ACID)
- S1P1 receptor agonists (autoimmune diseases), Arena Pharmaceuticals
- APD 334
- 6WH8495MMH
- etrasimodum
- RefChem:139296
- Etrasimod [USAN]
- Etrasimod(APD334)
- Etrasimod (USAN)
- MFCD28502134
- ETRASIMOD [INN]
- ETRASIMOD [WHO-DD]
- UNII-6WH8495MMH
- GTPL9331
- orb1296117
- SCHEMBL1919311
- SCHEMBL29359174
- C26H26F3NO3
- CHEBI:229230
- MVGWUTBTXDYMND-QGZVFWFLSA-N
- GLXC-10642
- EX-A1633
- BDBM50041691
- AKOS032944972
- APD334-003
- compound 4 [PMID: 25516790]
- CS-6181
- AC-35444
- DA-63317
- FC158571
- HY-12789
- MS-28349
- SY326202
- D10930
- F798898
- APD334 L-Arginine
Look up ETRASIMOD in the interactive SynDRA portal →